-
181
Impaired lipolysis in propionic acidemia: A new metabolic myopathy?
Published 2020-05-01Get full text
Article -
182
-
183
-
184
Unraveling unmet needs in ketogenic dietary services: An ERN EpiCARE survey
Published 2024-08-01Get full text
Article -
185
-
186
Clinical, diagnostic and therapeutic characteristics of mucopolysaccharidosis
Published 2023-04-01“…Conclusions: Mucopolysaccharidoses are a group of inherited metabolic diseases. In mucopolysaccharidosis an adequate diagnosis is essential to improve the life expectancy of patients. …”
Get full text
Article -
187
Use of valproate and carbamazepine in the therapy of epilepsy (guidelines for the practitioner)
Published 2018-12-01“…VA should not be used (if the clinical situation allows) in women of childbearing age, in some infantile epileptic encephalopathy, inherited metabolic diseases, and chromosomal abnormalities. …”
Get full text
Article -
188
Evaluation of patients with phenylketonuria before and after screening in Qazvin Province, Iran
Published 2021-11-01“…CONCLUSION: Early diagnosis and treatment of children with inherited metabolic diseases can prevent brain damage and retardation in them and reduce the financial and psychological burden of treating these children by maintaining their intelligence quotient (IQ).…”
Get full text
Article -
189
Inhibition of in vitro CO2 production and lipid synthesis by 2-hydroxybutyric acid in rat brain
Published 2001-05-01“…2-Hydroxybutyric acid appears at high concentrations in situations related to deficient energy metabolism (e.g., birth asphyxia) and also in inherited metabolic diseases affecting the central nervous system during neonatal development, such as "cerebral" lactic acidosis, glutaric aciduria type II, dihydrolipoyl dehydrogenase (E3) deficiency, and propionic acidemia. …”
Get full text
Article -
190
-
191
-
192
Clinical proton MR spectroscopy in central nervous system disorders.
Published 2014“…The clinical usefulness of (1)H MR spectroscopy has been established for brain neoplasms, neonatal and pediatric disorders (hypoxia-ischemia, inherited metabolic diseases, and traumatic brain injury), demyelinating disorders, and infectious brain lesions. …”
Journal article -
193
Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention
Published 2022-04-01Get full text
Article -
194
-
195
Cholinesterase Deficiency Syndrome—A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson’s Disease
Published 2022-09-01“…A family is described as having two recessively inherited metabolic diseases and three differently affected children. …”
Get full text
Article -
196
Postpyloric nutrition to prevent emergencies – a step away from repeat inpatient care in children with methylmalonic acidaemia and propionic acidaemia – a case report of four cases...
Published 2023-02-01“…Methylmalonic acidaemia (MMA) and propionic acidaemia (PA) are very rare autosomal recessive inherited metabolic diseases from the group of organoacidopathies. …”
Get full text
Article -
197
Training competencies in adult metabolic medicine: A survey of working adult metabolic medicine physicians
Published 2022-09-01“…Abstract The rapid expansion of the number of adult patients with inherited metabolic diseases (IMDs) has created demand for physicians with expertise in the field of adult metabolic medicine (AMM). …”
Get full text
Article -
198
Oxidative Stress in Mucopolysaccharidoses: Pharmacological Implications
Published 2021-09-01“…Although mucopolysaccharidoses (MPS) are caused by mutations in genes coding for enzymes responsible for degradation of glycosaminoglycans, storage of these compounds is crucial but is not the only pathomechanism of these severe, inherited metabolic diseases. Among various factors and processes influencing the course of MPS, oxidative stress appears to be a major one. …”
Get full text
Article -
199
Lysosomal storage disorders: Molecular basis and laboratory testing
Published 2011-03-01“…<p>Abstract</p> <p>Lysosomal storage disorders (LSDs) are a large group of more than 50 different inherited metabolic diseases which, in the great majority of cases, result from the defective function of specific lysosomal enzymes and, in cases, of non-enzymatic lysosomal proteins or non-lysosomal proteins involved in lysosomal biogenesis. …”
Get full text
Article -
200
Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice.
Published 2010“…Glycosphingolipid storage diseases are a group of inherited metabolic diseases in which glycosphingolipids accumulate due to their impaired lysosomal breakdown. …”
Journal article